Arkolith/Insider Trading/BIOA/Form 4

Enright Patrick G

DirectorBioAge Labs, Inc. (BIOA) · full profile →Form 4 · filed Sep 27, 2024
Net Buying
Open-Market Buys
$7.2M
Open-Market Sells
$0
Net Open-Market Flow
$7.2M
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 27, 2024Conversion(C)1.3M——1.3M
Sep 27, 2024Buy(P)400K$18.00$7.2M1.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 27, 2024Conversion(C)5.8M——0
Sep 25, 2024Grant(A)15K—$015K

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-024046) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML